Breaking News Instant updates and real-time market news.

CLOV

Clover Health

$9.30 /

-0.16 (-1.69%)

16:54
09/09/21
09/09
16:54
09/09/21
16:54

Clover Health initiated with an Underperform at Cowen

Cowen analyst Gary Taylor initiated coverage of Clover Health with an Underperform rating and $7.00 price target. The analyst states that he is skeptical regarding the company core business thesis that its overlaying Clover Assistant along with the unmanaged FFS physician practices will yield best-in-class care management and per-capita medical costs. Clover is has also become a popular meme stock on Reddit, which has created extreme volatility in the share price of late, Taylor tells investors in a research note.

  • 09

    Sep

CLOV Clover Health
$9.30 /

-0.16 (-1.69%)

09/02/21
Fly Intel: Top five analyst initiations
09/02/21 Citi
Clover Health re-initiated with a Neutral at Citi
07/12/21
Fly Intel: Top five analyst downgrades
07/12/21 JPMorgan
Clover Health downgraded to Underweight from Neutral at JPMorgan

TODAY'S FREE FLY STORIES

Hot Stocks
BowX Acquisition files proxy statement, to vote Oct. 19 on WeWork deal » 09:32
09/20/21
09/20
09:32
09/20/21
09:32
BOWX

BowX Acquisition

$9.99 /

-0.035 (-0.35%)

, WE

WeWork

/

+

BowX Acquisition Corp.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BOWX BowX Acquisition
$9.99 /

-0.035 (-0.35%)

WE WeWork
/

+

BOWX BowX Acquisition
$9.99 /

-0.035 (-0.35%)

WE WeWork
/

+

BOWX BowX Acquisition
$9.99 /

-0.035 (-0.35%)

BOWX BowX Acquisition
$9.99 /

-0.035 (-0.35%)

Downgrade
NFI Group downgraded to Hold from Buy at TD Securities » 09:31
09/20/21
09/20
09:31
09/20/21
09:31
NFYEF

NFI Group

$23.35 /

-0.28 (-1.18%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFYEF NFI Group
$23.35 /

-0.28 (-1.18%)

NFYEF NFI Group
$23.35 /

-0.28 (-1.18%)

08:09 Today Stifel
NFI Group downgraded to Sell from Hold at Stifel
08/30/21 CIBC
NFI Group downgraded to Neutral from Outperformer at CIBC
08/06/21 TD Securities
NFI Group price target raised to C$35 from C$33 at TD Securities
07/23/21 Stifel
NFI Group downgraded to Hold ahead of earnings at Stifel
NFYEF NFI Group
$23.35 /

-0.28 (-1.18%)

Hot Stocks
Hawkins completes acquisition of Southeast Water Systems » 09:30
09/20/21
09/20
09:30
09/20/21
09:30
HWKN

Hawkins

$33.91 /

-0.6 (-1.74%)

Hawkins has completed the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HWKN Hawkins
$33.91 /

-0.6 (-1.74%)

HWKN Hawkins
$33.91 /

-0.6 (-1.74%)

03/10/21 BWS Financial
Hawkins price target raised to $44 from $33.50 at BWS Financial
01/29/21 BWS Financial
Hawkins price target raised to $67 from $62 at BWS Financial
01/19/21 BWS Financial
Hawkins to benefit from higher chlorine prices, says BWS Financial
HWKN Hawkins
$33.91 /

-0.6 (-1.74%)

HWKN Hawkins
$33.91 /

-0.6 (-1.74%)

Upgrade
Canadian National upgraded to Buy from Hold at TD Securities » 09:29
09/20/21
09/20
09:29
09/20/21
09:29
CNI

Canadian National

$118.30 /

+2.45 (+2.11%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNI Canadian National
$118.30 /

+2.45 (+2.11%)

CNI Canadian National
$118.30 /

+2.45 (+2.11%)

07:44 Today Cowen
Canadian National price target raised to $119 from $110 at Cowen
09/19/21 BMO Capital
Canadian National downgraded to Market Perform from Outperform at BMO Capital
09/17/21 RBC Capital
Canadian National reinstated at Outperform from Sector Perform at RBC Capital
09/16/21 National Bank
Canadian National price target raised to C$144 from C$139 at National Bank
CNI Canadian National
$118.30 /

+2.45 (+2.11%)

CNI Canadian National
$118.30 /

+2.45 (+2.11%)

CNI Canadian National
$118.30 /

+2.45 (+2.11%)

CNI Canadian National
$118.30 /

+2.45 (+2.11%)

Hot Stocks
Brunswick's Advanced Systems Group acquires SemahTronix » 09:29
09/20/21
09/20
09:29
09/20/21
09:29
BC

Brunswick

$97.46 /

+0.07 (+0.07%)

Brunswick Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BC Brunswick
$97.46 /

+0.07 (+0.07%)

BC Brunswick
$97.46 /

+0.07 (+0.07%)

08/02/21 BMO Capital
Brunswick price target raised to $110 from $105 at BMO Capital
06/25/21 B. Riley
Brunswick acquisition to 'meaningfully boost' market share, says B. Riley
06/18/21 JPMorgan
Brunswick price target raised to $113 from $106 at JPMorgan
06/17/21 Truist
Brunswick price target lowered to $120 from $125 at Truist
BC Brunswick
$97.46 /

+0.07 (+0.07%)

Hot Stocks
AIkido Pharma secures equity interest in tele-health company, Kerna Health » 09:28
09/20/21
09/20
09:28
09/20/21
09:28
AIKI

AIkido Pharma

/

+

AIkido Pharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AIKI AIkido Pharma
/

+

  • 17
    Feb
Hot Stocks
Merit Medical announces results in first-in-human study of WRAPSODY » 09:28
09/20/21
09/20
09:28
09/20/21
09:28
MMSI

Merit Medical

$71.70 /

-0.61 (-0.84%)

Merit Medical Systems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MMSI Merit Medical
$71.70 /

-0.61 (-0.84%)

MMSI Merit Medical
$71.70 /

-0.61 (-0.84%)

09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
07/30/21 Barrington
Merit Medical price target raised to $79 from $71 at Barrington
07/30/21 Needham
Merit Medical price target raised to $83 from $73 at Needham
07/30/21 Piper Sandler
Merit Medical price target raised to $79 from $73 at Piper Sandler
MMSI Merit Medical
$71.70 /

-0.61 (-0.84%)

MMSI Merit Medical
$71.70 /

-0.61 (-0.84%)

Recommendations
CMS update 'small speed bump' for ShockWave Medical, says Piper Sandler » 09:27
09/20/21
09/20
09:27
09/20/21
09:27
SWAV

ShockWave Medical

$227.24 /

-3.83 (-1.66%)

The Centers for Medicare…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWAV ShockWave Medical
$227.24 /

-3.83 (-1.66%)

SWAV ShockWave Medical
$227.24 /

-3.83 (-1.66%)

09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/03/21 Piper Sandler
CMS new-tech-add-on payment approved for ShockWave, says Piper Sandler
08/03/21 Piper Sandler
AMA meeting agenda positive for ShockWave Medical, says Piper Sandler
07/15/21 Piper Sandler
Piper Sandler sees minimal exposure risk to Shockwave Medical from CMS rate cuts
SWAV ShockWave Medical
$227.24 /

-3.83 (-1.66%)

Hot Stocks
DuPont joins Water Resilience Coalition, signs CEO Water Mandate » 09:27
09/20/21
09/20
09:27
09/20/21
09:27
DD

DuPont

$68.92 /

-1.71 (-2.42%)

DuPont announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DD DuPont
$68.92 /

-1.71 (-2.42%)

DD DuPont
$68.92 /

-1.71 (-2.42%)

08/04/21 Citi
DuPont price target raised to $102 from $96 at Citi
07/06/21 Credit Suisse
DuPont assumed with a Neutral at Credit Suisse
05/26/21 Morgan Stanley
DuPont resumed with an Equal Weight at Morgan Stanley
05/14/21 Argus
DuPont price target raised to $93 from $81 at Argus
DD DuPont
$68.92 /

-1.71 (-2.42%)

DD DuPont
$68.92 /

-1.71 (-2.42%)

DD DuPont
$68.92 /

-1.71 (-2.42%)

DD DuPont
$68.92 /

-1.71 (-2.42%)

Hot Stocks
Pilgrim's Pride forms special committee to evaluate JBS unsolicited proposal » 09:27
09/20/21
09/20
09:27
09/20/21
09:27
PPC

Pilgrim's Pride

$28.25 /

+ (+0.00%)

The board of directors of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PPC Pilgrim's Pride
$28.25 /

+ (+0.00%)

PPC Pilgrim's Pride
$28.25 /

+ (+0.00%)

06/03/21 Barclays
Pilgrim's Pride price target raised to $28 from $25 at Barclays
04/30/21 BMO Capital
Pilgrim's Pride price target raised to $28 from $21 at BMO Capital
04/09/21 Stephens
Tyson Foods price target raised to $90 from $80 at Stephens
02/08/21 Stephens
Pilgrim's Pride upgraded to Overweight on improving chicken view at Stephens
PPC Pilgrim's Pride
$28.25 /

+ (+0.00%)

PPC Pilgrim's Pride
$28.25 /

+ (+0.00%)

PPC Pilgrim's Pride
$28.25 /

+ (+0.00%)

Hot Stocks
Carfax announces CEO retirement, succession plan » 09:25
09/20/21
09/20
09:25
09/20/21
09:25
INFO

IHS Markit

$121.70 /

-2.16 (-1.74%)

CARFAX announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INFO IHS Markit
$121.70 /

-2.16 (-1.74%)

INFO IHS Markit
$121.70 /

-2.16 (-1.74%)

09/16/21 Oppenheimer
S&P Global price target raised to $550 from $476 at Oppenheimer
07/15/21 Deutsche Bank
IHS Markit price target raised to $127 from $123 at Deutsche Bank
07/15/21 Deutsche Bank
S&P Global price target raised to $450 from $435 at Deutsche Bank
07/07/21 RBC Capital
S&P Global initiated with an Outperform at RBC Capital
INFO IHS Markit
$121.70 /

-2.16 (-1.74%)

  • 29
    Jun
  • 11
    May
INFO IHS Markit
$121.70 /

-2.16 (-1.74%)

INFO IHS Markit
$121.70 /

-2.16 (-1.74%)

Conference/Events
Morgan Stanley economist to hold an analyst/industry conference call » 09:25
09/20/21
09/20
09:25
09/20/21
09:25

Chief Economic Advisor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Truist biotechnology analysts to hold an analyst/industry conference call » 09:25
09/20/21
09/20
09:25
09/20/21
09:25
EDIT

Editas Medicine

$63.31 /

+2.27 (+3.72%)

Biotech Analysts discuss…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EDIT Editas Medicine
$63.31 /

+2.27 (+3.72%)

EDIT Editas Medicine
$63.31 /

+2.27 (+3.72%)

09/10/21
Fly Intel: Top five analyst upgrades
09/10/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
09/09/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
08/09/21
Fly Intel: Top five analyst upgrades
EDIT Editas Medicine
$63.31 /

+2.27 (+3.72%)

  • 21
    Jan
EDIT Editas Medicine
$63.31 /

+2.27 (+3.72%)

EDIT Editas Medicine
$63.31 /

+2.27 (+3.72%)

Hot Stocks
AbbVie submits regulatory application to FDA fror risankizumab-rzaa » 09:24
09/20/21
09/20
09:24
09/20/21
09:24
ABBV

AbbVie

$107.75 /

-0.33 (-0.31%)

AbbVie announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

06:31 Today Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

Hot Stocks
Roche says new Phase 3 data support Tecentriq benefit in early-stage lung cancer » 09:22
09/20/21
09/20
09:22
09/20/21
09:22
RHHBY

Roche

$46.07 /

-0.75 (-1.60%)

Roche announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$46.07 /

-0.75 (-1.60%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

06:31 Today Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
RHHBY Roche
$46.07 /

-0.75 (-1.60%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

Recommendations
DraftKings heading for another beat-and-raise quarter, says Loop Capital » 09:22
09/20/21
09/20
09:22
09/20/21
09:22
DKNG

DraftKings

$60.41 /

+0.4 (+0.67%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DKNG DraftKings
$60.41 /

+0.4 (+0.67%)

DKNG DraftKings
$60.41 /

+0.4 (+0.67%)

09/14/21 Wells Fargo
DraftKings initiated with Overweight, $73 target at Wells Fargo
09/14/21 Craig-Hallum
DraftKings price target raised to $70 from $60 at Craig-Hallum
09/09/21 Macquarie
Macquarie says own online gaming into 'major catalyst' of NFL kickoff
08/19/21 Loop Capital
DraftKings Q3 revenues tracking 'well ahead of consensus', says Loop Capital
DKNG DraftKings
$60.41 /

+0.4 (+0.67%)

  • 07
    Oct
DKNG DraftKings
$60.41 /

+0.4 (+0.67%)

DKNG DraftKings
$60.41 /

+0.4 (+0.67%)

DKNG DraftKings
$60.41 /

+0.4 (+0.67%)

Hot Stocks
DoorDash expands marketplace offering with alcohol » 09:21
09/20/21
09/20
09:21
09/20/21
09:21
DASH

DoorDash

$222.65 /

+1.27 (+0.57%)

DoorDash announced it is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DASH DoorDash
$222.65 /

+1.27 (+0.57%)

DASH DoorDash
$222.65 /

+1.27 (+0.57%)

09/16/21
Fly Intel: Top five analyst upgrades
09/16/21 BofA
DoorDash upgraded to Buy at BofA on non-restaurant ordering opportunity
09/16/21 BofA
DoorDash upgraded to Buy from Neutral at BofA
09/13/21 Goldman Sachs
DoorDash initiated with a Neutral at Goldman Sachs
DASH DoorDash
$222.65 /

+1.27 (+0.57%)

  • 19
    Aug
  • 20
    May
  • 09
    Dec
DASH DoorDash
$222.65 /

+1.27 (+0.57%)

DASH DoorDash
$222.65 /

+1.27 (+0.57%)

DASH DoorDash
$222.65 /

+1.27 (+0.57%)

General news
White House to lift EU, U.K. restrictions for vaccinated travelers, FT reports » 09:20
09/20/21
09/20
09:20
09/20/21
09:20
MRNA

Moderna

$429.30 /

-11.54 (-2.62%)

, BNTX

BioNTech

$358.75 /

-13.75 (-3.69%)

, PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

The White House is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$429.30 /

-11.54 (-2.62%)

BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

MRNA Moderna
$429.30 /

-11.54 (-2.62%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
08/06/21
Fly Intel: Top five analyst downgrades
BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
08/20/21 Canaccord
BioNTech price target raised to $450 from $240 at Canaccord
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

06:31 Today Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
MRNA Moderna
$429.30 /

-11.54 (-2.62%)

BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

MRNA Moderna
$429.30 /

-11.54 (-2.62%)

BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

MRNA Moderna
$429.30 /

-11.54 (-2.62%)

BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

MRNA Moderna
$429.30 /

-11.54 (-2.62%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

Syndicate
Mattress Firm exploring potential initial public offering » 09:18
09/20/21
09/20
09:18
09/20/21
09:18
TPX

Tempur Sealy

$47.62 /

-0.04 (-0.08%)

, CSPR

Casper Sleep

$4.99 /

+0.05 (+1.01%)

Mattress Firm Group Inc.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TPX Tempur Sealy
$47.62 /

-0.04 (-0.08%)

CSPR Casper Sleep
$4.99 /

+0.05 (+1.01%)

TPX Tempur Sealy
$47.62 /

-0.04 (-0.08%)

07/30/21 Wedbush
Tempur Sealy price target raised to $53 from $45 at Wedbush
04/30/21 Truist
Tempur Sealy price target raised to $50 from $45 at Truist
04/30/21 Piper Sandler
Tempur Sealy share weakness a buying opportunity, says Piper Sandler
04/12/21 UBS
Tempur Sealy price target raised to $48 from $40 at UBS
CSPR Casper Sleep
$4.99 /

+0.05 (+1.01%)

07/14/21 Goldman Sachs
Casper Sleep initiated with a Sell at Goldman Sachs
04/26/21 Wedbush
Casper Sleep upgraded to Outperform at Wedbush on better path forward
04/26/21 Wedbush
Casper Sleep upgraded to Outperform from Neutral at Wedbush
02/25/21 Citi
Casper Sleep price target raised to $12 from $10 at Citi
TPX Tempur Sealy
$47.62 /

-0.04 (-0.08%)

CSPR Casper Sleep
$4.99 /

+0.05 (+1.01%)

TPX Tempur Sealy
$47.62 /

-0.04 (-0.08%)

CSPR Casper Sleep
$4.99 /

+0.05 (+1.01%)

Hot Stocks
AIM ImmunoTech provides update on pending Phase 2a trial of Ampligen » 09:17
09/20/21
09/20
09:17
09/20/21
09:17
AIM

AIM ImmunoTech

$2.02 /

+0.06 (+3.06%)

AIM ImmunoTech provided a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AIM AIM ImmunoTech
$2.02 /

+0.06 (+3.06%)

AIM AIM ImmunoTech
$2.02 /

+0.06 (+3.06%)

Hot Stocks
L3Harris gets approval from SDA for missile tracking satellites plan » 09:16
09/20/21
09/20
09:16
09/20/21
09:16
LHX

L3Harris Technologies

$222.59 /

+1.545 (+0.70%)

L3Harris Technologies …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LHX L3Harris Technologies
$222.59 /

+1.545 (+0.70%)

LHX L3Harris Technologies
$222.59 /

+1.545 (+0.70%)

09/08/21 Wolfe Research
L3Harris Technologies initiated with a Peer Perform at Wolfe Research
08/11/21
Fly Intel: Top five analyst downgrades
08/11/21 Morgan Stanley
L3Harris Technologies downgraded to Equal Weight from Overweight at Morgan Stanley
08/04/21 Credit Suisse
L3Harris Technologies price target raised to $254 from $243 at Credit Suisse
LHX L3Harris Technologies
$222.59 /

+1.545 (+0.70%)

LHX L3Harris Technologies
$222.59 /

+1.545 (+0.70%)

Hot Stocks
eHealth appoints Christine Janofsky as Chief Financial Officer » 09:15
09/20/21
09/20
09:15
09/20/21
09:15
EHTH

eHealth

$37.85 /

+0.69 (+1.86%)

eHealth announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EHTH eHealth
$37.85 /

+0.69 (+1.86%)

EHTH eHealth
$37.85 /

+0.69 (+1.86%)

07/30/21 Craig-Hallum
eHealth price target lowered to $75 from $85 at Craig-Hallum
07/30/21 Credit Suisse
eHealth price target lowered to $75 from $90 at Credit Suisse
07/30/21 RBC Capital
eHealth price target lowered to $62 from $70 at RBC Capital
04/30/21 Barclays
eHealth price target raised to $80 from $75 at Barclays
EHTH eHealth
$37.85 /

+0.69 (+1.86%)

EHTH eHealth
$37.85 /

+0.69 (+1.86%)

Hot Stocks
Diana Shipping announces time charter contract for M/V Maera » 09:14
09/20/21
09/20
09:14
09/20/21
09:14
DSX

Diana Shipping

$5.85 /

-0.255 (-4.18%)

Diana Shipping announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DSX Diana Shipping
$5.85 /

-0.255 (-4.18%)

DSX Diana Shipping
$5.85 /

-0.255 (-4.18%)

09/13/21 H.C. Wainwright
Diana Shipping initiated with a Buy at H.C. Wainwright
03/16/21 Pareto
Diana Shipping upgraded to Hold from Sell at Pareto
02/23/21 Clarksons Platou
Diana Shipping price target raised to $5 from $3 at Clarksons Platou
02/23/21 Pareto
Diana Shipping downgraded to Sell from Hold at Pareto
DSX Diana Shipping
$5.85 /

-0.255 (-4.18%)

Hot Stocks
uCloudlink strengthens presence in South-East Asia with new partnership » 09:13
09/20/21
09/20
09:13
09/20/21
09:13
UCL

uCloudlink

$5.44 /

-0.52 (-8.72%)

UCLOUDLINK GROUP is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UCL uCloudlink
$5.44 /

-0.52 (-8.72%)

Hot Stocks
F5 Networks to acquire privately held Threat Stack for $68M » 09:12
09/20/21
09/20
09:12
09/20/21
09:12
FFIV

F5 Networks

$204.70 /

-3.83 (-1.84%)

F5 announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FFIV F5 Networks
$204.70 /

-3.83 (-1.84%)

FFIV F5 Networks
$204.70 /

-3.83 (-1.84%)

07/27/21 BofA
BofA upgrades F5 Networks to Buy after better than expected results
07/27/21 BofA
F5 Networks upgraded to Buy from Neutral at BofA
07/27/21 MKM Partners
F5 Networks price target raised to $248 from $229 at MKM Partners
07/27/21 Needham
F5 Networks price target raised to $265 from $255 at Needham
FFIV F5 Networks
$204.70 /

-3.83 (-1.84%)

FFIV F5 Networks
$204.70 /

-3.83 (-1.84%)

FFIV F5 Networks
$204.70 /

-3.83 (-1.84%)

FFIV F5 Networks
$204.70 /

-3.83 (-1.84%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.